콘텐츠로 건너뛰기
Merck
  • [Pharmacological treatment of spasticity in multiple sclerosis].

[Pharmacological treatment of spasticity in multiple sclerosis].

Revue neurologique (2012-06-29)
O Heinzlef, I Monteil-Roch
초록

The medicinal treatment of spasticity includes use of oral treatments (baclofène and tizanidine), botulinum toxin, intrathecal baclofène and local application of alcohol or phenol. However, spasticity may not be uncomfortable and may even be useful. Therefore, all spastic diseases do not systematically require treatment. First-line treatments (oral treatments and botulinum toxin) can be considered depending on the local or diffuse nature of the spasticity and depending on the etiology.

MATERIALS
제품 번호
브랜드
제품 설명

Supelco
Vigabatrin solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
(±)-Vigabatrin